Zacks Investment Research on MSN

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

Emergent Biosolutions (EBS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $1.37 per share a year ...
TipRanks on MSN

Emergent BioSolutions Raises Full-Year Revenue Guidance

Emergent Biosolutions ( (EBS) ) has shared an announcement. On October 29, 2025, Emergent BioSolutions reported its financial results for the third quarter of 2025, with total revenues of $231.1 ...

Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years

Emergent BioSolutions Inc. ( NYSE:EBS ) shareholders will doubtless be very grateful to see the share price up 56% ...

Emergent Biosolutions: Q3 Earnings Snapshot

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported profit of $51.2 million in its third quarter. On a per-share basis, the Gaithersburg, ...

Emergent Biosolutions Q3 2025 Earnings Preview

Emergent Biosolutions (EBS) is scheduled to announce Q3 earnings results on Wednesday, October 29th, after market close. The consensus EPS Estimate is $0.11 (-9 ...